Physician profile
Eric Brandon Smith
NPI 1982666939
$2,394.82
in general payments reported to CMS, 2019-2025
15 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.61 · 2021: $565 · 2022: $58.26 · 2023: $163 · 2024: $1,142 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.98 |
| Travel and Lodging | $543.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $852.24 | 2021-2025 | Mako, Triathlon, Insignia |
| Restor3d, INC. | $605.55 | 2024 | |
| Medical Device Business Services, INC. | $388.58 | 2021 | |
| Encore Medical, LP | $103.00 | 2025 | Djo Surgical |
| Depuy Synthes Sales INC. | $101.96 | 2024 | Milagro, Orthovisc |
| Heraeus Medical, LLC. | $78.78 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $48.09 | 2023-2024 | Xarelto |
| Zimmer Biomet Holdings, INC. | $46.20 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.26 | 2019 | |
| Dexcom, INC. | $36.04 | 2025 | Dexcom G6 Transmitter |
| Convatec INC. | $29.35 | 2019 | |
| Fidia Pharma USA INC. | $21.41 | 2025 | Hymovis |
| Depuy Synthes Products, INC. | $18.26 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.04 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.